NYSE - Delayed Quote USD
Boston Scientific Corporation (BSX)
At close: October 31 at 4:00 PM EDT
Pre-Market: 7:03 AM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 26 | 18 | 31 | 30 |
| Avg. Estimate | 0.65 | 0.64 | 2.46 | 2.79 |
| Low Estimate | 0.63 | 0.61 | 2.44 | 2.72 |
| High Estimate | 0.68 | 0.68 | 2.49 | 2.87 |
| Year Ago EPS | 0.55 | 0.56 | 2.05 | 2.46 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 24 | 16 | 30 | 29 |
| Avg. Estimate | 4.4B | 4.39B | 16.58B | 18.63B |
| Low Estimate | 4.26B | 4.25B | 16.44B | 18.22B |
| High Estimate | 4.5B | 4.55B | 16.69B | 19.34B |
| Year Ago Sales | 3.73B | 3.86B | 14.24B | 16.58B |
| Sales Growth (year/est) | 18.00% | 13.90% | 16.40% | 12.30% |
Earnings History
| CURRENCY IN USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.51 | 0.51 | 0.58 | 0.59 |
| EPS Actual | 0.55 | 0.56 | 0.62 | 0.63 |
| Difference | 0.04 | 0.05 | 0.04 | 0.04 |
| Surprise % | 7.80% | 9.80% | 6.90% | 6.80% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.65 | 0.64 | 2.46 | 2.79 |
| 7 Days Ago | 0.65 | 0.64 | 2.45 | 2.78 |
| 30 Days Ago | 0.64 | 0.64 | 2.41 | 2.73 |
| 60 Days Ago | 0.64 | 0.63 | 2.41 | 2.72 |
| 90 Days Ago | 0.64 | 0.63 | 2.41 | 2.72 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 4 | 4 |
| Up Last 30 Days | 21 | 7 | 30 | 28 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | 1 | 1 | -- |
Growth Estimates
| CURRENCY IN USD | BSX | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 18.20% | -- | -- | 5.10% |
| Next Qtr. | 14.30% | -- | -- | 11.80% |
| Current Year | 20.00% | -- | -- | 2.10% |
| Next Year | 13.40% | -- | -- | 12.30% |
| Next 5 Years (per annum) | 13.81% | -- | -- | 11.68% |
| Past 5 Years (per annum) | 19.41% | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | Needham: Hold | 10/31/2024 |
| Maintains | Bernstein: Outperform to Outperform | 10/24/2024 |
| Maintains | Morgan Stanley: Overweight to Overweight | 10/24/2024 |
| Maintains | RBC Capital: Outperform to Outperform | 10/24/2024 |
| Maintains | Wells Fargo: Overweight to Overweight | 10/24/2024 |
| Maintains | Citigroup: Buy to Buy | 10/24/2024 |
Related Tickers
MDT Medtronic plc
89.25
-1.38%
EW Edwards Lifesciences Corporation
67.01
-2.36%
SYK Stryker Corporation
356.28
-1.97%
ABT Abbott Laboratories
113.37
-0.94%
DXCM DexCom, Inc.
70.48
-1.84%
ZBH Zimmer Biomet Holdings, Inc.
106.92
-2.63%
PRCT PROCEPT BioRobotics Corporation
90.00
-3.26%
NARI Inari Medical, Inc.
48.40
+2.76%
PHG Koninklijke Philips N.V.
26.20
-0.46%
TMDX TransMedics Group, Inc.
81.97
+0.06%